Together, these modifications reduce IGFBP binding affinity by approximately 100-fold while preserving full agonist activity at the type 1 IGF receptor (IGF-1R), creating a molecule with dramatically enhanced bioavailability in biological systems
this has not been studied for LR3 specifically but is inferred from native IGF-1 pharmacology [1]
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, et al
SURMOUNT-1 demonstrated average weight loss of approximately 21% at the highest dose
References Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al
Semaglutide should be storaged as specified from the manufacturers guidelines, and the temperature should be maintained until the expiration date to ensure potency and safety